TGFBI
Basic information
Region (hg38): 5:136028988-136063818
Previous symbols: [ "CSD3", "LCD1", "CSD1", "CSD2" ]
Links
Phenotypes
GenCC
Source:
- epithelial basement membrane dystrophy (Supportive), mode of inheritance: AD
- Thiel-Behnke corneal dystrophy (Supportive), mode of inheritance: AD
- Reis-Bucklers corneal dystrophy (Supportive), mode of inheritance: AD
- granular corneal dystrophy type I (Supportive), mode of inheritance: AD
- granular corneal dystrophy type II (Supportive), mode of inheritance: AD
- lattice corneal dystrophy type I (Supportive), mode of inheritance: AD
- granular corneal dystrophy type I (Definitive), mode of inheritance: AD
- Reis-Bucklers corneal dystrophy (Definitive), mode of inheritance: AD
- Thiel-Behnke corneal dystrophy (Definitive), mode of inheritance: AD
- granular corneal dystrophy type II (Definitive), mode of inheritance: AD
- lattice corneal dystrophy type I (Definitive), mode of inheritance: AD
- granular corneal dystrophy type I (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Corneal dystrophy, lattice type I; Corneal dystrophy, lattice type IIIA; Corneal dystrophy of Bowman layer, type I; Corneal dystrophy, Avellino type; Corneal dystrophy, Reis-Bucklers type; Corneal dystrophy, Thiel-Behnke type; Corneal dystrophy, Groenouw type I; Corneal dystrophy, epithelial basement membrane | AD | General | It has been reported that in affected individuals with CDA, LASIK can increase the deposition of visually significant corneal opacities; Corneal epithelial debridement and fibronectin eye drops has been described as potentially delaying the need for keratoplasty or phototherapeutic keratoplasty; Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Ophthalmologic | 9780098; 9727509; 9497262; 10442892; 11867580; 11923233; 15531312; 15019320; 15885785; 15111592; 15790870; 16652336; 16606891; 22080335; 22155582; 22194646; 22355247; 22575726 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (7 variants)
- Lattice corneal dystrophy Type I (3 variants)
- Groenouw corneal dystrophy type I (2 variants)
- Avellino corneal dystrophy (2 variants)
- Epithelial-stromal TGFBI dystrophy (2 variants)
- 7 conditions (1 variants)
- Reis-Bucklers' corneal dystrophy (1 variants)
- Thiel-Behnke corneal dystrophy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TGFBI gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 14 | 27 | ||||
missense | 51 | 70 | ||||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | 4 | |||
non coding | 12 | 18 | ||||
Total | 8 | 6 | 75 | 19 | 12 |
Highest pathogenic variant AF is 0.0000328
Variants in TGFBI
This is a list of pathogenic ClinVar variants found in the TGFBI region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-136029060-C-G | Inborn genetic diseases | Uncertain significance (Oct 12, 2022) | ||
5-136029069-T-C | Inborn genetic diseases | Uncertain significance (Jun 02, 2024) | ||
5-136029105-G-C | Inborn genetic diseases • TGFBI-related disorder | Uncertain significance (Aug 13, 2021) | ||
5-136029122-G-T | Inborn genetic diseases | Uncertain significance (Jun 12, 2023) | ||
5-136029132-C-T | Inborn genetic diseases | Uncertain significance (Sep 17, 2021) | ||
5-136029169-G-C | Inborn genetic diseases | Uncertain significance (Sep 22, 2023) | ||
5-136029203-C-A | Corneal dystrophy | Conflicting classifications of pathogenicity (Jan 18, 2024) | ||
5-136033769-C-T | Corneal dystrophy | Uncertain significance (Jan 12, 2018) | ||
5-136033818-A-C | Inborn genetic diseases | Uncertain significance (Apr 07, 2023) | ||
5-136033834-A-C | Inborn genetic diseases | Uncertain significance (Mar 30, 2024) | ||
5-136033852-G-A | Inborn genetic diseases | Uncertain significance (Dec 27, 2023) | ||
5-136033864-G-A | Likely benign (Jan 04, 2022) | |||
5-136044097-C-T | Corneal dystrophy | Uncertain significance (Jan 13, 2018) | ||
5-136044107-A-G | Corneal dystrophy | Uncertain significance (Jan 12, 2018) | ||
5-136046343-C-T | Inborn genetic diseases | Uncertain significance (Mar 31, 2024) | ||
5-136046357-C-T | Corneal dystrophy | Uncertain significance (Jan 12, 2018) | ||
5-136046358-G-A | Inborn genetic diseases | Uncertain significance (Jun 18, 2024) | ||
5-136046370-G-A | Corneal dystrophy | Uncertain significance (Apr 28, 2017) | ||
5-136046373-G-A | Uncertain significance (Nov 03, 2023) | |||
5-136046384-C-A | Corneal dystrophy | Uncertain significance (Jan 13, 2018) | ||
5-136046403-G-C | not specified | Benign (May 04, 2022) | ||
5-136046406-C-A | Groenouw corneal dystrophy type I • Epithelial-stromal TGFBI dystrophy | Pathogenic (Sep 21, 2021) | ||
5-136046406-C-T | Lattice corneal dystrophy Type I • Epithelial-stromal TGFBI dystrophy | Pathogenic (Mar 08, 2024) | ||
5-136046407-G-A | Avellino corneal dystrophy • Lattice corneal dystrophy Type I | Pathogenic (Feb 09, 2024) | ||
5-136046407-G-T | Reis-Bucklers' corneal dystrophy • Avellino corneal dystrophy | Pathogenic (Sep 12, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TGFBI | protein_coding | protein_coding | ENST00000442011 | 17 | 34924 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.97e-8 | 0.993 | 124640 | 0 | 29 | 124669 | 0.000116 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.102 | 393 | 399 | 0.986 | 0.0000232 | 4410 |
Missense in Polyphen | 204 | 220.94 | 0.92333 | 2399 | ||
Synonymous | 0.974 | 155 | 171 | 0.905 | 0.0000108 | 1411 |
Loss of Function | 2.46 | 17 | 32.1 | 0.530 | 0.00000167 | 372 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000211 | 0.000210 |
Ashkenazi Jewish | 0.0000999 | 0.0000993 |
East Asian | 0.0000556 | 0.0000556 |
Finnish | 0.000186 | 0.000186 |
European (Non-Finnish) | 0.000134 | 0.000133 |
Middle Eastern | 0.0000556 | 0.0000556 |
South Asian | 0.0000654 | 0.0000654 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role in cell adhesion (PubMed:8024701). May play a role in cell-collagen interactions (By similarity). {ECO:0000250|UniProtKB:O11780, ECO:0000269|PubMed:8024701}.;
- Disease
- DISEASE: Corneal dystrophy, epithelial basement membrane (EBMD) [MIM:121820]: A bilateral anterior corneal dystrophy characterized by grayish epithelial fingerprint lines, geographic map-like lines, and dots (or microcysts) on slit-lamp examination. Pathologic studies show abnormal, redundant basement membrane and intraepithelial lacunae filled with cellular debris. {ECO:0000269|PubMed:16652336}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Corneal dystrophy, Groenouw type 1 (CDGG1) [MIM:121900]: A rare form of stromal corneal dystrophy characterized by multiple small deposits in the superficial central corneal stroma, and progressive visual impairment. {ECO:0000269|PubMed:15623763}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Corneal dystrophy, lattice type 1 (CDL1) [MIM:122200]: A form of lattice corneal dystrophy, a class of inherited stromal amyloidoses characterized by pathognomonic branching lattice figures in the cornea. CDL1 is characterized by progressive visual impairment, and the presence of delicate, double-contoured, interdigitating, elongated deposits that form a reticular pattern in the corneal stroma. Systemic amyloidosis is absent. Recurrent corneal ulceration sometimes occurs. {ECO:0000269|PubMed:10837380, ECO:0000269|PubMed:11413411, ECO:0000269|PubMed:14597039, ECO:0000269|PubMed:15531312, ECO:0000269|PubMed:15623763, ECO:0000269|PubMed:15838722, ECO:0000269|PubMed:16541014, ECO:0000269|PubMed:17013691, ECO:0000269|PubMed:9799082}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Corneal dystrophy, Thiel-Behnke type (CDTB) [MIM:602082]: A bilateral disorder of the cornea characterized by progressive honeycomb-like, subepithelial corneal opacities with recurrent erosions. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Corneal dystrophy, Reis-Bucklers type (CDRB) [MIM:608470]: A bilateral disorder of the cornea characterized by intermittent attacks of ocular irritation, recurrent painful corneal erosions starting in childhood, corneal opacities in a geographic pattern at the level of the Bowman layer, and a progressive decrease of visual acuity. The lesions are primarily in Bowman membrane with secondary involvement of the epithelium and superficial part of the stroma. Bowman membrane is almost completely replaced by pathologic materials including disoriented collagen fibrils. {ECO:0000269|PubMed:10660331, ECO:0000269|PubMed:15623763, ECO:0000269|PubMed:9780098}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Corneal dystrophy, lattice type 3A (CDL3A) [MIM:608471]: A form of lattice corneal dystrophy, a class of inherited stromal amyloidoses characterized by pathognomonic branching lattice figures in the cornea. CDL3A is characterized by decreased visual acuity, and the presence of thick, ropy branching lattice lines and accumulations of amyloid deposits in the corneal stroma. Systemic amyloidosis is absent. CDL3A clinically resembles to lattice corneal dystrophy type 3, but differs in that its age of onset is 70 to 90 years. It has an autosomal dominant inheritance pattern. {ECO:0000269|PubMed:15790870, ECO:0000269|PubMed:9497262}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Corneal dystrophy, Avellino type (CDA) [MIM:607541]: A corneal disease resulting in reduced visual acuity and characterized by gray, crumb-like granular deposits in the anterior third of the stroma in each corneal button. Fusiform amyloid deposits, histochemically and morphologically identical to those of lattice corneal dystrophy, are found in the deeper stroma. Additional features include recurrent corneal erosions, and glare and decreased night vision. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Beta3 integrin cell surface interactions;Beta1 integrin cell surface interactions;Beta2 integrin cell surface interactions
(Consensus)
Recessive Scores
- pRec
- 0.707
Intolerance Scores
- loftool
- 0.132
- rvis_EVS
- -0.66
- rvis_percentile_EVS
- 16.02
Haploinsufficiency Scores
- pHI
- 0.493
- hipred
- Y
- hipred_score
- 0.694
- ghis
- 0.505
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.740
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tgfbi
- Phenotype
- vision/eye phenotype; immune system phenotype; neoplasm; hematopoietic system phenotype; growth/size/body region phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype;
Zebrafish Information Network
- Gene name
- tgfbi
- Affected structure
- fast muscle cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- angiogenesis;chondrocyte differentiation;cell adhesion;negative regulation of cell adhesion;visual perception;cell population proliferation;extracellular matrix organization;cellular protein metabolic process;response to stimulus
- Cellular component
- extracellular region;basement membrane;extracellular space;trans-Golgi network;plasma membrane;extracellular matrix;collagen-containing extracellular matrix;extracellular exosome
- Molecular function
- integrin binding;extracellular matrix structural constituent;protein binding;collagen binding;cell adhesion molecule binding;extracellular matrix binding